Camilla Bjørn Jensen, PhD

Senior pharmacoepidemiologist
Copenhagen Phase IV Unit – Phase4CPH Section for Data, Biostatistics and Pharmacoepidemiology, Center for Clinical Research and Prevention
Frederiksberg, Denmark

Camilla Bjørn Jensen is a senior pharmacoepidemiologist at the Copenhagen Phase IV Unit (Phase4CPH), Center for Clinical Research and Prevention at Frederiksberg Hospital. She holds a PhD in Public Health and Epidemiology from the University of Copenhagen.
Camilla has extensive experience using Danish national registers and holds strong competencies in epidemiology, statistics, and data management. Camilla's research focuses include pharmacological treatment of cystic fibrosis, inflammatory bowel disease, and hypercholesterolemia.

Disclosure information not submitted.

Presentation(s):

• Real-world outcomes: Lung clearance index improvements in Danish children with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.

  Wednesday, August 28, 2024
  2:15 PM – 2:30 PM CEST